|
Suarez-Garcia I, Moreno C, Ruiz-Alguero M, Perez-Elias MJ, Navarro M, Diez Martinez M, Viciana P, Perez-Martinez L, Gorgolas M, Amador C, de Zarraga MA, Jarrin I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study. AIDS Res Ther. 2020 Jul 20;17(1):45. doi: 10.1186/s12981-020-00302-2. PubMed PMID: 32690099; PubMed Central PMCID: PMC7372769.
AÑO: 2020; IF: 2.25
|
32690099
|
Rosado-Sanchez I, Rodriguez-Gallego E, Peraire J, Vilades C, Herrero P, Fanjul F, Gutierrez F, Bernal E, Pelazas R, Leal M, Veloso S, Lopez-Dupla M, Blanco J, Vidal F, Pacheco YM, Rull A. Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients. Clin Sci (Lond). 2019 Apr 29;133(8):997-1010. doi: 10.1042/CS20190111. Print 2019 Apr 30. PubMed PMID: 30952809.
AÑO: 2019; IF: 5.223
|
|
Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillen M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadinanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidaviciene E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, Garcia-Garcia JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborin R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martinez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quiros S, Rendon A, Skrahina A, Smite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stosic M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study. Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3. PubMed PMID: 30953827.
AÑO: 2019; IF: 3.202
|
|
Valero Cifuentes S, Garcia Villalba E, Alcaraz Garcia A, Alcaraz Garcia MJ, Munoz Perez A, Pinera Salmeron P, Bernal Morell E. Prognostic value of pro-adrenomedullin and NT-proBNP in patients referred from the emergency department with influenza syndrome. Emergencias. 2019 Jun;31(3):180-184. English, Spanish. PubMed PMID: 31210450.
AÑO: 2019; IF: 5.345
|
|
Vitalle J, Terren I, Orrantia A, Perez-Garay R, Vidal F, Iribarren JA, Rodriguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F. CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients. Cell Mol Immunol. 2019 Dec;16(12):940-942. doi: 10.1038/s41423-019-0275-4. Epub 2019 Aug 29. No abstract available. PubMed PMID: 31467415; PubMed Central PMCID: PMC6884514.
AÑO: 2019; IF: 8.484
|